Article
Understanding the Molecular Basis of Acute Myeloid Leukemias: Where are we Now?
1 Nov 2017
Abstract excerpt
Although the treatment modalities for acute myeloid leukemia (AML) have not changed much over the past 40 years, distinct progress has been made in deciphering the basic biology underlying the pathogenesis of this group of hematological disorders. Studies show that AML development is a multicause, multistep and multipathway process. Accordingly, AMLs constitute a heterogeneous group of diseases. The thorough...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
